Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
105.39 -0.08 / -0.08%
Data as of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
105.14 -0.25 / -0.24%
 
Volume: 417.4K
AstraZeneca Posts Positive Data on its Type II Diabetes Drug - Analyst Blog
6:04pm / Zacks.com
Stock Market News for September 19, 2014 - Market News
Sep 19 / Zacks.com
Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog
5:32pm / Zacks.com
VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
Sep 19 / Zacks.com
3 Stocks Reiterated As A Buy: HAL, NFLX, GILD
5:08pm / TheStreet.com
US Stock Futures Signal Higher Start On Wall Street
Sep 19 / Benzinga
Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog
3:50pm / Zacks.com
Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
Sep 18 / Zacks.com
Picking Through Some Small-Caps
11:39am / TheStreet.com
Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
Sep 18 / Zacks.com
OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape
9:35am / Zacks.com
Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
Sep 18 / Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Sep 22 / Zacks.com
Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
Sep 18 / Zacks.com
Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog
Sep 22 / Zacks.com
Rotating Into Blue Chips
Sep 18 / TheStreet.com
Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog
Sep 22 / Zacks.com
2 Columbia Growth Funds Notch Impressive Three-Month Performance
Sep 18 / Benzinga
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Sep 22 / Zacks.com
Europe struggles to catch US biotech bulls
Sep 18 / FT.com
Surprising Silver Lining for Gilead Sciences, inc. Stock
Sep 22 / MotleyFool.com
Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
Sep 18 / MotleyFool.com
3 Stocks Pulling The Drugs Industry Downward
Sep 22 / TheStreet.com
ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
Sep 18 / Zacks.com
Gilead Sciences: A Preview of Important HIV Drug Study Results
Sep 22 / TheStreet.com
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape
Sep 18 / Zacks.com
Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher - Tale of the Tape
Sep 22 / Zacks.com
Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
Sep 18 / Zacks.com
Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape
Sep 22 / Zacks.com
Gilead Sciences, inc. Stock's Incoming Game Changer
Sep 18 / MotleyFool.com
Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape
Sep 22 / Zacks.com
3 Best Stocks for Investing in Biotech
Sep 18 / MotleyFool.com
VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
Sep 19 / Zacks.com
3 Huge Stocks on Traders' Radars
Sep 18 / TheStreet.com
Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
Sep 19 / Zacks.com
Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog
Sep 17 / Zacks.com
Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog
Sep 19 / Zacks.com
Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
Sep 17 / Zacks.com
Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog
Sep 19 / Zacks.com
UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
Sep 17 / Zacks.com
Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog
Sep 19 / Zacks.com
Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog
Sep 17 / Zacks.com
Is Merck KGaA on Track with its "Fit for 2018" Program? - Analyst Blog
Sep 19 / Zacks.com
AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog
Sep 17 / Zacks.com
Notable Upgrades: Gilead Sciences (GILD), Ideal Power (IPWR), American Eagle Outfitte...
Sep 19 / Investing Channel
Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog
Sep 17 / Zacks.com
Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
Sep 19 / MotleyFool.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - ...
Sep 17 / Zacks.com
5 Things Gilead Sciences, Inc. Management Wants You to Know
Sep 19 / MotleyFool.com
Stock Market News for September 17, 2014 - Market News
Sep 17 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.